Cutera (NASDAQ:CUTR) Now Covered by StockNews.com

Investment analysts at StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a note issued to investors on Sunday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Price Performance

NASDAQ:CUTR opened at $0.36 on Friday. The firm has a market capitalization of $7.27 million, a price-to-earnings ratio of -0.05 and a beta of 1.32. The company’s 50-day moving average is $0.43 and its two-hundred day moving average is $0.54. Cutera has a 1-year low of $0.28 and a 1-year high of $3.00.

Institutional Investors Weigh In On Cutera

A hedge fund recently bought a new stake in Cutera stock. Sculptor Capital LP purchased a new stake in Cutera, Inc. (NASDAQ:CUTR) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned 0.82% of Cutera as of its most recent filing with the SEC. 90.70% of the stock is currently owned by institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.